Kava

product on market Capsule plnt Safety: 60/100
60/100

Review before taking

  • Kava: 400mg is 1.6× the Tolerable Upper Intake Level (250mg)
  • 100% of ingredients have research evidence
C Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · grounded in 1 source · methodology

Kava is associated with anxiolytic effects and may help reduce symptoms of anxiety, supported by moderate research evidence. However, the safety score reflects potential concerns regarding hepatotoxicity and liver health. Users should be aware of these risks when considering supplementation.

AI-generated summary based on research evidence. Not medical advice.

Alerts

Safety Alerts

Kava: 400mg is 1.6× the Tolerable Upper Intake Level (250mg)

AI-generated · Qwen 3.6 · grounded in 2 sources · methodology

This product received a low safety score because it contains 400mg of Kava, which is significantly higher than the recommended upper limit of 250mg.

Label

Product Label

Label for Kava
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Vegetarian Capsule(s)
Serving Size
Botanical
Product Type
100%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

400 mg
Exceeds UL by 1.6× (UL: 250 mg) 15 studies (A:0, B:5)

Other Ingredients

Vegetable Cellulose
Claims

Label Claims — Verification

Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Directions: Take one (1) vegetarian capsule daily, preferably with a meal.

Warnings & Precautions

Warning: Consult your healthcare provider prior to use if you are pregnant, nursing, taking any medication or have any medical conditions. CRN Kava Warning: Not for use by pregnant or nursing women, or persons under the age of 18. Consult a health care practitioner prior to use if you have or have had liver problems, frequently use alcoholic beverages or are taking any medication.

CRN Kava Warning: Not for use by pregnant or nursing women, or persons under the age of 18.

Stop use and see a health care practitioner if you develop symptoms that may signal liver problems, including jaundice (yellowing of the skin or whites of the eyes) and brown urine, as well as other non-specific symptoms including nausea, vomiting, light colored stools, unusual tiredness, weakness, stomach or abdominal pain, and loss of appetite. Excessive use, or use with products that cause drowsiness, may impair your ability to operate a vehicle or heavy equipment. Not for use with alcoholic beverages. The US FDA advises that a potential risk of rare but severe liver injury may be associated with kava-containing dietary supplements.

Keep out of reach of children.

Tamper evident Do not use if outer seal is broken or missing.

Formulation Notes

Stress support Promotes relaxation

Gluten free Dairy free Soy free Nut free

K Parve K-1604

Additional Information

Pure living

Store in a cool, dry place.

Quality Promise Tested & Trusted

K Parve K-1604

Metadata

Product Details

UPC / SKU7 66536 01789 8
DSLD Entry Date2020-05-22
Product TypeBotanical
FormCapsule
Brandplnt
DSLD ID221595
Data Updated2026-04-11
Research

Research Evidence

19
Research Sources
48
Avg Quality
8
Rct
5
Systematic Review
4
Meta Analysis
2
Clinical Trial
B Kava extract for treating anxiety
Meta Analysis The Cochrane database of systematic reviews 2003 PubMed
B Kava for Generalized Anxiety Disorder: A Review of Current Evidence
Meta Analysis Journal of alternative and complementary medicine (New York, N.Y.) 2018 PubMed DOI
B Kava extract for treating anxiety
Systematic Review The Cochrane database of systematic reviews 2001 PubMed
B Kava extract for treating anxiety
Systematic Review The Cochrane database of systematic reviews 2002 PubMed
B The effectiveness and safety of Kava Kava for treating anxiety symptoms: A systematic review and analysis of randomized clinical trials
Systematic Review Complementary therapies in clinical practice 2018 PubMed DOI
C Kava for generalised anxiety disorder: A 16-week double-blind, randomised, placebo-controlled study
Rct The Australian and New Zealand journal of psychiatry 2020 PubMed DOI
C Kava and St. John's Wort: current evidence for use in mood and anxiety disorders
Systematic Review Journal of alternative and complementary medicine (New York, N.Y.) 2009 PubMed DOI
C Neuroimaging Insights: Kava's (Piper methysticum) Effect on Dorsal Anterior Cingulate Cortex GABA in Generalized Anxiety Disorder.
Rct Nutrients PubMed DOI
C The risk-benefit profile of commonly used herbal therapies: Ginkgo, St. John's Wort, Ginseng, Echinacea, Saw Palmetto, and Kava
Meta Analysis Annals of internal medicine 2002 PubMed
C Efficacy of kava extract for treating anxiety: systematic review and meta-analysis
Meta Analysis Journal of clinical psychopharmacology 2000 PubMed
View all evidence for Kava →
Compare

Similar Products

View all Kava products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.